SHARE
Neurostimulation Devices Market

Neurostimulation Devices - Global Market Outlook (2019-2027)

4.6 (18 reviews)
Published: September 2020 ID: SMRC19889
4.6 (18 reviews)
Published: September 2020 ID: SMRC19889

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Neurostimulation Devices Market is accounted for $5.61 billion in 2019 and is expected to reach $16.58 billion by 2027 growing at a CAGR of 14.5% during the forecast period. Some of the key factors propelling the growth of the market are growing prevalence of neurological disorders, growing adoption of innovative products, and rising demand for minimally invasive surgery. However, the lack of skilled healthcare practitioners is the restraining factor for the growth of the market.
 

Neurostimulation Devices - Global Market Outlook (2019 -2027)


Equipment used for neuromodulation is known as neurostimulation device. This device helps in the treatment of neurologic disorders by assuring the delivery of electrical stimulation to the intended parts of the patient’s brain, peripheral nervous system, and spinal cord.

By product, the spinal cord stimulators (SCS) segment is expected to grow at a significant market share during the forecast period owing to the high market penetration of commercially available products in this segment. Based on geography, North America is anticipated to hold considerable market share during the forecast period which is attributed to the growing geriatric population, changing lifestyles, and increasing consumption of alcohol and junk food.

Some of the key players in Neurostimulation Devices Market include Medtronic, Cyberonics, Boston Scientific Corporation, St. Jude Medical, Nevro Corporation, Electromedical Products International (EPI), NeuroPace, Inc., Aleva Neurotherapeutics SA, BioControl Medical, EnteroMedics Inc, Bioness Inc, Autonomic Technologies, Neuronetics, Inc, Multi Radiance Medical, Inc, American Imex, Amrex Electrotherapy Equipment, Synapse Biomedical, LivaNova PLC, DePuy Synthes Inc, NeuroSigma Inc, Abbott Laboratories, and Integer Holdings Corporation. 

Types Covered:
• External
• Implantable

Products Covered:
• Cochlear Implants (CI)
• Spinal Cord Stimulators (SCS)
• Deep Brain Stimulators (DBS)
• Sacral Nerve Stimulators (SNS)
• Gastric Electric Stimulators (GES)
• Percutaneous Tibial Nerve Stimulators
• Auditory Brainstem Implant
• Hypoglossal Nerve Stimulation
• Transcranial Magnetic Stimulators
• Vagus Nerve Stimulators (VNS)

End Users Covered:
• Hospitals
• Research Institutes/Scientific Research Laboratories
• Cognitive Care Centers
• Rehabilitation Centers
• Medical Clinic
• Ambulatory Surgery Centers
• Specialty Clinics

Applications Covered:
• Neurological Disorders
• Chronic Pain
• Movement Disorders
• Ischemia
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Hearing Loss
• Gastroparesis
• Pain Management
• Neurologic Urinary and Fecal Incontinence
• Essential Tremor
• Depressive Disorder
• Dystonia
• Respiratory Disorders

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain
o Rest of Europe      
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary       
      
2 Preface      
  
 2.1 Abstract       
 2.2 Stake Holders      
 2.3 Research Scope      
 2.4 Research Methodology     
  2.4.1 Data Mining     
  2.4.2 Data Analysis     
  2.4.3 Data Validation     
  2.4.4 Research Approach     
 2.5 Research Sources      
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions     
         
3 Market Trend Analysis      
 3.1 Introduction       
 3.2 Drivers       
 3.3 Restraints       
 3.4 Opportunities      
 3.5 Threats       
 3.6 Product Analysis      
 3.7 Application Analysis      
 3.8 End User Analysis      
 3.9 Emerging Markets      
 3.10 Impact of Covid-19      
          
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes      
 4.4 Threat of new entrants     
 4.5 Competitive rivalry      
         
5 Global Neurostimulation Devices Market, By Type    
 5.1 Introduction      
 5.2 External       
  5.2.1 Transcranial Magnetic Stimulation (TMS)   
  5.2.2 Transcutaneous Electrical Nerve Stimulation (TENS)  
 5.3 Implantable      
         
6 Global Neurostimulation Devices Market, By Product   
 6.1 Introduction      
 6.2 Cochlear Implants (CI)     
 6.3 Spinal Cord Stimulators (SCS)     
 6.4 Deep Brain Stimulators (DBS)     
 6.5 Sacral Nerve Stimulators (SNS)     
 6.6 Gastric Electric Stimulators (GES)    
 6.7 Percutaneous Tibial Nerve Stimulators    
 6.8 Auditory Brainstem Implant     
 6.9 Hypoglossal Nerve Stimulation     
 6.10 Transcranial Magnetic Stimulators    
 6.11 Vagus Nerve Stimulators (VNS)     
  6.11.1 Noninvasive Vagus Nerve Stimulator    
  6.11.2 Invasive Vagus Nerve Stimulator   
         
7 Global Neurostimulation Devices Market, By End User   
 7.1 Introduction      
 7.2 Hospitals       
 7.3 Research Institutes/Scientific Research Laboratories   
 7.4 Cognitive Care Centers      
 7.5 Rehabilitation Centers     
 7.6 Medical Clinic      
 7.7 Ambulatory Surgery Centers     
 7.8 Specialty Clinics      
         
8 Global Neurostimulation Devices Market, By Application   
 8.1 Introduction      
 8.2 Neurological Disorders     
  8.2.1 Alzheimer’s     
  8.2.2 Epilepsy      
  8.2.3 Parkinson's Disease     
 8.3 Chronic Pain      
 8.4 Movement Disorders      
 8.5 Ischemia       
 8.6 Treatment Resistant Depression(TRD)    
 8.7 Obsessive Compulsive Disorder(OCD)    
 8.8 Hearing Loss      
 8.9 Gastroparesis      
 8.10 Pain Management      
 8.11 Neurologic Urinary and Fecal Incontinence    
 8.12 Essential Tremor      
 8.13 Depressive Disorder      
 8.14 Dystonia       
 8.15 Respiratory Disorders      
         
9 Global Neurostimulation Devices Market, By Geography   
 9.1 Introduction      
 9.2 North America      
  9.2.1 US      
  9.2.2 Canada      
  9.2.3 Mexico      
 9.3 Europe       
  9.3.1 Germany      
  9.3.2 UK      
  9.3.3 Italy      
  9.3.4 France      
  9.3.5 Spain      
  9.3.6 Rest of Europe     
 9.4 Asia Pacific      
  9.4.1 Japan      
  9.4.2 China      
  9.4.3 India      
  9.4.4 Australia      
  9.4.5 New Zealand     
  9.4.6 South Korea     
  9.4.7 Rest of Asia Pacific     
 9.5 South America      
  9.5.1 Argentina      
  9.5.2 Brazil      
  9.5.3 Chile      
  9.5.4 Rest of South America    
 9.6 Middle East & Africa      
  9.6.1 Saudi Arabia     
  9.6.2 UAE      
  9.6.3 Qatar       
  9.6.4 South Africa     
  9.6.5 Rest of Middle East & Africa    
         
10 Key Developments       
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures  
 10.2 Acquisitions & Mergers     
 10.3 New Product Launch      
 10.4 Expansions      
 10.5 Other Key Strategies      
         
11 Company Profiling       
 11.1 Medtronic      
 11.2 Cyberonics      
 11.3 Boston Scientific Corporation     
 11.4 St. Jude Medical      
 11.5 Nevro Corporation      
 11.6 Electromedical Products International (EPI)    
 11.7 NeuroPace, Inc.      
 11.8 Aleva Neurotherapeutics SA     
 11.9 BioControl Medical      
 11.10 EnteroMedics Inc      
 11.11 Bioness Inc      
 11.12 Autonomic Technologies     
 11.13 Neuronetics, Inc       
 11.14 Multi Radiance Medical, Inc     
 11.15 American Imex      
 11.16 Amrex Electrotherapy Equipment    
 11.17 Synapse Biomedical      
 11.18 LivaNova PLC      
 11.19 DePuy Synthes Inc      
 11.20 NeuroSigma Inc      
 11.21 Abbott Laboratories      
 11.22 Integer Holdings Corporation     


List of Tables        
1 Global Neurostimulation Devices Market Outlook, By Region (2018-2027) ($MN) 
2 Global Neurostimulation Devices Market Outlook, By Type (2018-2027) ($MN) 
3 Global Neurostimulation Devices Market Outlook, By External (2018-2027) ($MN) 
4 Global Neurostimulation Devices Market Outlook, By Transcranial Magnetic Stimulation (TMS) (2018-2027) ($MN)
5 Global Neurostimulation Devices Market Outlook, By Transcutaneous Electrical Nerve Stimulation (TENS) (2018-2027) ($MN)
6 Global Neurostimulation Devices Market Outlook, By Implantable (2018-2027) ($MN) 
7 Global Neurostimulation Devices Market Outlook, By Product (2018-2027) ($MN) 
8 Global Neurostimulation Devices Market Outlook, By Cochlear Implants (CI) (2018-2027) ($MN)
9 Global Neurostimulation Devices Market Outlook, By Spinal Cord Stimulators (SCS) (2018-2027) ($MN)
10 Global Neurostimulation Devices Market Outlook, By Deep Brain Stimulators (DBS) (2018-2027) ($MN)
11 Global Neurostimulation Devices Market Outlook, By Sacral Nerve Stimulators (SNS) (2018-2027) ($MN)
12 Global Neurostimulation Devices Market Outlook, By Gastric Electric Stimulators (GES) (2018-2027) ($MN)
13 Global Neurostimulation Devices Market Outlook, By Percutaneous Tibial Nerve Stimulators (2018-2027) ($MN)
14 Global Neurostimulation Devices Market Outlook, By Auditory Brainstem Implant (2018-2027) ($MN)
15 Global Neurostimulation Devices Market Outlook, By Hypoglossal Nerve Stimulation (2018-2027) ($MN)
16 Global Neurostimulation Devices Market Outlook, By Transcranial Magnetic Stimulators (2018-2027) ($MN)
17 Global Neurostimulation Devices Market Outlook, By Vagus Nerve Stimulators (VNS) (2018-2027) ($MN)
18 Global Neurostimulation Devices Market Outlook, By Noninvasive Vagus Nerve Stimulator (2018-2027) ($MN)
19 Global Neurostimulation Devices Market Outlook, By Invasive Vagus Nerve Stimulator (2018-2027) ($MN)
20 Global Neurostimulation Devices Market Outlook, By End User (2018-2027) ($MN) 
21 Global Neurostimulation Devices Market Outlook, By Hospitals (2018-2027) ($MN) 
22 Global Neurostimulation Devices Market Outlook, By Research Institutes/Scientific Research Laboratories (2018-2027) ($MN)
23 Global Neurostimulation Devices Market Outlook, By Cognitive Care Centers (2018-2027) ($MN)
24 Global Neurostimulation Devices Market Outlook, By Rehabilitation Centers (2018-2027) ($MN)
25 Global Neurostimulation Devices Market Outlook, By Medical Clinic (2018-2027) ($MN) 
26 Global Neurostimulation Devices Market Outlook, By Ambulatory Surgery Centers (2018-2027) ($MN)
27 Global Neurostimulation Devices Market Outlook, By Specialty Clinics (2018-2027) ($MN)
28 Global Neurostimulation Devices Market Outlook, By Application (2018-2027) ($MN)  
29 Global Neurostimulation Devices Market Outlook, By Neurological Disorders (2018-2027) ($MN)
30 Global Neurostimulation Devices Market Outlook, By Alzheimer’s (2018-2027) ($MN) 
31 Global Neurostimulation Devices Market Outlook, By Epilepsy (2018-2027) ($MN) 
32 Global Neurostimulation Devices Market Outlook, By Parkinson's Disease (2018-2027) ($MN)
33 Global Neurostimulation Devices Market Outlook, By Chronic Pain (2018-2027) ($MN) 
34 Global Neurostimulation Devices Market Outlook, By Movement Disorders (2018-2027) ($MN)
35 Global Neurostimulation Devices Market Outlook, By Ischemia (2018-2027) ($MN) 
36 Global Neurostimulation Devices Market Outlook, By Treatment Resistant Depression(TRD) (2018-2027) ($MN)
37 Global Neurostimulation Devices Market Outlook, By Obsessive Compulsive Disorder(OCD) (2018-2027) ($MN)
38 Global Neurostimulation Devices Market Outlook, By Hearing Loss (2018-2027) ($MN) 
39 Global Neurostimulation Devices Market Outlook, By Gastroparesis (2018-2027) ($MN) 
40 Global Neurostimulation Devices Market Outlook, By Pain Management (2018-2027) ($MN)
41 Global Neurostimulation Devices Market Outlook, By Neurologic Urinary and Fecal Incontinence (2018-2027) ($MN)
42 Global Neurostimulation Devices Market Outlook, By Essential Tremor (2018-2027) ($MN)
43 Global Neurostimulation Devices Market Outlook, By Depressive Disorder (2018-2027) ($MN)
44 Global Neurostimulation Devices Market Outlook, By Dystonia (2018-2027) ($MN) 
45 Global Neurostimulation Devices Market Outlook, By Respiratory Disorders (2018-2027) ($MN)
         
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials